Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.

Planas R, Santos R, Tomas-Ojer P, Cruciani C, Lutterotti A, Faigle W, Schaeren-Wiemers N, Espejo C, Eixarch H, Pinilla C, Martin R, Sospedra M.

Sci Transl Med. 2018 Oct 10;10(462). pii: eaat4301. doi: 10.1126/scitranslmed.aat4301.

PMID:
30305453
2.

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.

Calvo-Barreiro L, Eixarch H, Montalban X, Espejo C.

Autoimmun Rev. 2018 Feb;17(2):165-174. doi: 10.1016/j.autrev.2017.11.019. Epub 2017 Nov 28. Review.

PMID:
29191793
3.

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Miralles M, Eixarch H, Tejero M, Costa C, Hirota K, Castaño AR, Puig M, Stockinger G, Montalban X, Bosch A, Espejo C, Chillon M.

Neurotherapeutics. 2017 Oct;14(4):1095-1106. doi: 10.1007/s13311-017-0545-8.

4.

Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation.

Eixarch H, Calvo-Barreiro L, Montalban X, Espejo C.

Brain Behav Immun. 2018 Feb;68:1-10. doi: 10.1016/j.bbi.2017.02.019. Epub 2017 Feb 27. Review.

PMID:
28249802
5.

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.

Casacuberta-Serra S, Costa C, Eixarch H, Mansilla MJ, López-Estévez S, Martorell L, Parés M, Montalban X, Espejo C, Barquinero J.

Exp Neurol. 2016 Dec;286:50-60. doi: 10.1016/j.expneurol.2016.09.012. Epub 2016 Sep 28.

PMID:
27693617
6.

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.

Gutiérrez-Franco A, Eixarch H, Costa C, Gil V, Castillo M, Calvo-Barreiro L, Montalban X, Del Río JA, Espejo C.

Mol Neurobiol. 2017 Aug;54(6):4820-4831. doi: 10.1007/s12035-016-0154-2. Epub 2016 Oct 6.

PMID:
27714632
7.

Neurofilament light chain level is a weak risk factor for the development of MS.

Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M.

Neurology. 2016 Sep 13;87(11):1076-84. doi: 10.1212/WNL.0000000000003085. Epub 2016 Aug 12. Erratum in: Neurology. 2016 Nov 8;87(19):2068.

8.

Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design.

Gutiérrez-Franco A, Costa C, Eixarch H, Castillo M, Medina-Rodríguez EM, Bribián A, de Castro F, Montalban X, Espejo C.

Clin Immunol. 2016 Feb;163:22-33. doi: 10.1016/j.clim.2015.12.005. Epub 2015 Dec 10.

PMID:
26686462
9.

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.

Costa C, Martínez-Sáez E, Gutiérrez-Franco A, Eixarch H, Castro Z, Ortega-Aznar A, Ramón Y Cajal S, Montalban X, Espejo C.

Mult Scler. 2015 Nov;21(13):1632-43. doi: 10.1177/1352458515599848. Epub 2015 Oct 2.

PMID:
26432853
10.

Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.

Mansilla MJ, Costa C, Eixarch H, Tepavcevic V, Castillo M, Martin R, Lubetzki C, Aigrot MS, Montalban X, Espejo C.

PLoS One. 2014 Aug 25;9(8):e105737. doi: 10.1371/journal.pone.0105737. eCollection 2014.

11.

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE.

Marín N, Mecha M, Espejo C, Mestre L, Eixarch H, Montalban X, Álvarez-Cermeño JC, Guaza C, Villar LM.

J Immunol Res. 2014;2014:156380. doi: 10.1155/2014/156380. Epub 2014 Apr 27.

12.

Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Marín N, Eixarch H, Mansilla MJ, Rodríguez-Martín E, Mecha M, Guaza C, Álvarez-Cermeño JC, Montalban X, Villar LM, Espejo C.

Clin Exp Immunol. 2014 Feb;175(2):202-7. doi: 10.1111/cei.12233.

13.

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.

Eixarch H, Mansilla MJ, Costa C, Kunkel SL, Montalban X, Godessart N, Espejo C.

Neurosci Lett. 2013 Apr 29;541:161-6. doi: 10.1016/j.neulet.2013.02.038. Epub 2013 Mar 1.

PMID:
23466692
14.

Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.

Eixarch H, Gutiérrez-Franco A, Montalban X, Espejo C.

Trends Mol Med. 2013 Mar;19(3):157-64. doi: 10.1016/j.molmed.2013.01.003. Epub 2013 Feb 16.

PMID:
23419749
15.

Myeloid-derived suppressor cells are generated during retroviral transduction of murine bone marrow.

Gomez A, Espejo C, Eixarch H, Casacuberta-Serra S, Mansilla MJ, Sanchez R, Pereira S, Lopez-Estevez S, Gimeno R, Montalban X, Barquinero J.

Cell Transplant. 2014 Jan;23(1):73-85. doi: 10.3727/096368912X658971. Epub 2012 Nov 27.

PMID:
23192196
16.

Towards the standardisation of the neuroblastoma (neuro-2a) cell-based assay for ciguatoxin-like toxicity detection in fish: application to fish caught in the Canary Islands.

Caillaud A, Eixarch H, de la Iglesia P, Rodriguez M, Dominguez L, Andree KB, Diogène J.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(6):1000-10. doi: 10.1080/19440049.2012.660707. Epub 2012 Mar 7.

PMID:
22394180
17.

Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.

Torres-Torronteras J, Gómez A, Eixarch H, Palenzuela L, Pizzorno G, Hirano M, Andreu AL, Barquinero J, Martí R.

Gene Ther. 2011 Aug;18(8):795-806. doi: 10.1038/gt.2011.24. Epub 2011 Mar 31.

PMID:
21451581
18.

Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

Eixarch H, Gómez A, Kádár E, George M, Martínez N, Espejo C, Pétriz J, Gimeno R, Barquinero J.

Mol Ther. 2009 Nov;17(11):1904-9. doi: 10.1038/mt.2009.198. Epub 2009 Aug 25.

19.

Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

Eixarch H, Espejo C, Gómez A, Mansilla MJ, Castillo M, Mildner A, Vidal F, Gimeno R, Prinz M, Montalban X, Barquinero J.

Mol Ther. 2009 May;17(5):897-905. doi: 10.1038/mt.2009.42. Epub 2009 Mar 10. Erratum in: Mol Ther. 2009 Jul;17(7):1303.

20.

Retroviral vectors: new applications for an old tool.

Barquinero J, Eixarch H, Pérez-Melgosa M.

Gene Ther. 2004 Oct;11 Suppl 1:S3-9. Review.

PMID:
15454951
21.

Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.

Puig T, Kádár E, Limón A, Cancelas JA, Eixarch H, Luquín L, García M, Barquinero J.

Gene Ther. 2002 Nov;9(21):1472-9.

Supplemental Content

Loading ...
Support Center